Allurion Technologies Inc. (ALUR) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Natick, MA, アメリカ. 現CEOは Samuel G. Levy.
ALUR を有する IPO日 2021-03-29, 134 名の正社員, に上場 Other OTC, 時価総額 $6.79M.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
